Cloud DX (TSX-V:CDX, OTCQB:CDXFF) Inc announced it has appointed Neil Fraser to its board as an independent director.
Formerly president of Medtronic Canada, Fraser is currently a board member of Sona Nanotech (CSE:SONA) Inc and a member of various health-related councils including the CD Howe Institute and the International Working Group on Global Research, Development & Innovation with the BRG Institute.
Fraser has also acted as chair of Medtech Canada, board member of Baycrest Health Sciences, member of both the federal advisory panel on healthcare innovation and the Ontario Health Innovation Council.
READ: Cloud DX shares rise after consortium secures finance for patient monitoring project
Cloud DX (TSX-V:CDX, OTCQB:CDXFF) noted that several of Fraser’s writings on the topic of healthcare innovation in Canada have been published, and he has frequently been invited to share his expertise on value-based procurement and outcomes-based healthcare innovation. In 2022, he was awarded the Distinguished Leader Award by the Canadian College of Health Leaders.
Medtronic and Cloud DX have close ties, having an exclusive partnership agreement under which the partners co-market Cloud DX Connected Health solutions to hospitals and health authorities across Canada.
Recently, Cloud DX announced the $12.8 million Continuous Connected Patient Care (CCPC) project, in partnership with Medtronic PLC (NYSE:MDT) to integrate novel sensors from Medtronic with the Cloud DX Connected Health platform, and then jointly distribute the combined technology around the world.
"We're extremely pleased to welcome Neil to our board," says Cloud DX CEO and board chair Robert Kaul.
"His leadership of Medtronic spans a period of tremendous growth and innovation in the Medical Technology industry. Neil's guidance and counsel on the board will be critical to Cloud DX's success as we move into the next stage of our journey with our partners Medtronic, Teladoc (NYSE:TDOC) Health and others.”
Fraser told investors that he was very impressed with the team at Cloud DX during Medtronic’s partnership selection process.
“The company is delivering what we considered to be the best remote patient monitoring solution on the market today, and in addition, they have developed some remarkable new products that I believe will change outcomes and improve healthcare delivery all over the world,” the new board member said.
“I'm honored to be invited to join the Board of Directors and I look forward to being part of the Cloud DX story going forward."
Contact Angela at angela@proactiveinvestors.com
Follow her on Twitter @AHarmantas